Mammographic screening of women aged 40–49 years. Benefit, risk, and cost considerations
✍ Scribed by Stephen A. Feig
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 1000 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
M uch of the reluctance of some medical organizations to endorse mammographic screening in women ages 40 -49 years could be explained by the previous lack of statistically significant mortality reduction for women in this age group enrolled in randomized clinical trials (RCTs). 1 Such absence of ben
For some years, there has been a perceived need for more information on the effect of screening for breast cancer in women aged 40 to 49. Our approach was to gather the most recent data on screening in this age group, to assess the following quantities: the likely beneffi in mortality terms, measure